Magdalena Samborska
Overview
Explore the profile of Magdalena Samborska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pawinska-Wasikowska K, Czogala M, Bukowska-Strakova K, Surman M, Rygielska M, Ksiazek T, et al.
Front Pediatr
. 2024 Nov;
12:1482720.
PMID: 39483533
Background: A personalised approach to the treatment of acute myeloid leukemia (AML) in children and adolescents, as well as the development of supportive therapies, has significantly improved survival. Despite this,...
2.
Pawinska-Wasikowska K, Czogala M, Bukowska-Strakova K, Surman M, Rygielska M, Ksiazek T, et al.
Cancers (Basel)
. 2024 Mar;
16(6).
PMID: 38539480
Background: The reports of studies that compare the survival of adolescents and young adults with younger children with acute myeloid leukemia (AML) are contradictory. Patients And Methods: We retrospectively analyzed...
3.
Samborska M, Skalska-Sadowska J, Achkar R, Wachowiak J, Derwich K, Czogala M, et al.
Contemp Oncol (Pozn)
. 2024 Feb;
27(4):249-254.
PMID: 38405205
Introduction: This study aimed to present the clinical features and results of treatment of patients diagnosed with refractory or relapsed acute myeloid leukaemia (AML) in Polish Paediatric Leukaemia/Lymphoma Study Group...
4.
Pawinska-Wasikowska K, Czogala M, Skoczen S, Surman M, Rygielska M, Ksiazek T, et al.
Front Immunol
. 2024 Jan;
14:1268993.
PMID: 38187390
Background: Gemtuzumab ozogamicin (GO), one of the first targeted drugs used in oncology, consists of an anti-cluster of differentiation 33 (CD33) monoclonal antibody bound to a derivative of cytotoxic calicheamicin....
5.
Samborska M, Wziatek A, Mlynarczyk L, Dey S, Varghese N, Derwich K
J Infect Chemother
. 2023 Nov;
30(3):258-262.
PMID: 37913869
Infections are still a significant cause of mortality in children with hematologic malignancies. Fusariosis is a relatively rare and opportunistic infection, which may present dangerous course and a poor prognosis....
6.
Samborska M, Galli D, Achkar R, Thambyrajah S, Derwich K
J Pediatr Hematol Oncol
. 2023 Aug;
45(7):e917-e920.
PMID: 37526375
Constitutional mismatch repair deficiency syndrome is a genetic disorder resulting from a biallelic mutation in one of the following genes: MLH1, MSH2, MSH6, or PMS2. Individuals with constitutional mismatch repair...
7.
Bobeff K, Pastorczak A, Urbanska Z, Balwierz W, Juraszewska E, Wachowiak J, et al.
Children (Basel)
. 2023 May;
10(4).
PMID: 37189994
Venetoclax, the best established BH3-mimetic, is a practice-changing proapoptotic drug in blood cancers in adults. In paediatrics the data are fewer but exciting results were recently presented in relapsed or...
8.
Samborska M, Baranska M, Wachowiak J, Skalska-Sadowska J, Thambyrajah S, Czogala M, et al.
Front Oncol
. 2022 Jul;
12:935373.
PMID: 35875115
Introduction: Myeloid sarcoma (MS) is an extramedullary malignant tumor composed of immature myeloid cells. It occurs in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myeloid leukemia...
9.
Samborska M, Derwich K, Skalska-Sadowska J, Kurzawa P, Wachowiak J
Contemp Oncol (Pozn)
. 2017 Feb;
20(6):444-448.
PMID: 28239280
Myeloid sarcoma (MS) is a malignant extramedullary tumour, which consists of immature cells of myeloid origin. It may occur , concurrently or precede the diagnosis of acute myeloid leukemia (AML),...
10.
Skalska-Sadowska J, Januszkiewicz-Lewandowska D, Derwich K, Pieczonka A, Samborska M, Wachowiak J
Pediatr Blood Cancer
. 2015 Jan;
62(6):1070-1.
PMID: 25631405
Few patients in remission of Ph-positive chronic myelogenous leukemia (CML) develop Ph-negative MDS/AML, usually with clonal cytogenetic abnormalities. Isolated Ph-negative myeloid sarcoma (MS) is presented here as a form of...